NOT KNOWN FACTUAL STATEMENTS ABOUT PHARMA EXCIPIENTS

“The existing situation has exposed some structural weaknesses during the EU’s medicines supply chain along with a significant dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides explained. She suggested that supply chain challenges be resolved within an EU pharmaceutical tactic anticipated to generally be introduc